Travere Therapeutics, Inc. - COM (TVTX)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
87.9M
Holdings value Q2 2024
$723M
Value change Q2 2024
+$3.05M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
167
Number of buys Q2 2024
31
Number of sells Q2 2024
-23
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 7.09M $99.3M -$2.27M $13.99 46
2024 Q2 87.9M $723M +$3.05M $8.22 168
2024 Q1 87.6M $676M +$10.7M $7.71 170
2023 Q4 85.6M $769M +$28.1M $8.99 165
2023 Q3 82.4M $736M -$49.3M $8.94 171
2023 Q2 82.7M $1.27B -$86M $15.36 167
2023 Q1 84.2M $1.89B +$264M $22.49 173
2022 Q4 72.9M $1.53B +$36.5M $21.03 153
2022 Q3 69.7M $1.72B -$12K $24.64 168
2022 Q2 69.5M $1.68B +$17.4M $24.23 166
2022 Q1 69.4M $1.79B +$97.2M $25.77 169
2021 Q4 65.4M $2.03B +$61.5M $31.04 166
2021 Q3 60.8M $1.48B +$4.24M $24.25 145
2021 Q2 60.5M $883M -$73.5M $14.59 131
2021 Q1 62.6M $1.56B +$255M $24.97 147
2020 Q4 52.3M $1.42B +$1.42B $27.26 136